FindTrial
Sign In

A clinical trial to see the effect of ayurvedic formulation in the form of Local Application in the treatment of Vataja Abhishyanda with reference to Allergic Conjunctivitis

A randomized controlled trial to study the efficacy of Pathyadi Bidalaka and Olopatadine eye drop in Vataja Abhishyanda with reference to Allergic Conjunctivitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080401
Enrollment
44
Registered
2025-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H101- Acute atopic conjunctivitis

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from Vataja Abhishyanda with symptoms like Netra Toda (pricking sensation), Sangharsha (itching sensation), Shishirashruta (cold lacrimation), and Alpa shopha.

Exclusion criteria

Exclusion criteria: Patients with Pittaja, Kaphaja, Raktaja Abhishyanda lakshana. Patients suffering with any other severe ocular infection like corneal ulceration. Patients with any autoimmune disorder e.g., rheumatoid arthritis. Pregnant women and children.

Design outcomes

Primary

MeasureTime frame
Symptoms like - 1)Nistodan (pricking sensation) 2)Sangharsha (itching sensation) 3)Shishirashruta (cold lacrimation) 4)Alpha Shopha (conjunctival edema) Will be decreased and relief from Allergic ConjunctivitisTimepoint: Follow up on 4th and 7th day symptoms will be noted before and after the treatment.—

Secondary

MeasureTime frame
decrease in severity , duration of symptomsTimepoint: 18 months—

Countries

India

Contacts

Public ContactProf Dr Mrs Nilakshi S Pradhan

Mams Sumatibhai Shah Ayurved Mahavidhyalaya, Hadapsar, Pune

drnspradhan@yahoo.com9423580963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026